服务热线
15339069646服务热线
15339069646| Item | Name | Cat. No. | Tag/Conjugates |
| Anti-IL17A mAbs [Betinukibart Biosimilar] (MABL-4452) | MABL-4452 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-PDL1/CD274 mAbs [Betifisolimab Biosimilar] (MABL-4453) | MABL-4453 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-VEGFA mAbs [Bevacizumab Biosimilar] (MABL-4454) | MABL-4454 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-IL3RA/CD123;NCR1/NKP46/NKp46/LY94/CD335 mAbs [Bexatamig Biosimilar] (MABL-4455) | MABL-4455 | ELISA, FACS, Functional assay, in vivo binding | G1;G1, Kappa;Kappa |
| Anti-STAB1 mAbs [Bexmarilimab Biosimilar] (MABL-4456) | MABL-4456 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-CD74/HLA class II histocompatibility antigen gamma chain mAbs [Bezetabart Biosimilar] (MABL-445 | MABL-4457 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-Clostridium difficile Toxin A mAbs [Bezlotoxumab Biosimilar] (MABL-4458) | MABL-4458 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-FN extracellular domain B mAbs [Bifikafusp Biosimilar] (MABL-4459) | MABL-4459 | ELISA, FACS, Functional assay, in vivo binding | E, Kappa |
| Anti-ACVR2B mAbs [Bimagrumab Biosimilar] (MABL-4460) | MABL-4460 | ELISA, FACS, Functional assay, in vivo binding | G1, Lambda |
| Anti-SARS-CoV-2 Spike RBD mAbs [Bebtelovimab Biosimilar] (MABL-4432) | MABL-4432 | ELISA, FACS, Functional assay, in vivo binding | G1, Lambda |
| Anti-EGFR/ERBB1/HER1 mAbs [Becotatug Biosimilar] (MABL-4433) | MABL-4433 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-NGFB (Canine) mAbs [Bedinvetmab Biosimilar] (MABL-4434) | MABL-4434 | ELISA, FACS, Functional assay, in vivo binding | G2, Lambda |
| Anti-TFPI mAbs [Befovacimab Biosimilar] (MABL-4435) | MABL-4435 | ELISA, FACS, Functional assay, in vivo binding | G2, Lambda |
| Anti-DPP4/ADCP2/CD26 mAbs [Begelomab Biosimilar] (MABL-4436) | MABL-4436 | ELISA, FACS, Functional assay, in vivo binding | G2b, Kappa |
| Anti-TNFRSF17/CD269/BCMA/TNFRSF13A mAbs [Belantamab Biosimilar] (MABL-4437) | MABL-4437 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-TNFSF13B/CD257/BAFF mAbs [Belimumab Biosimilar] (MABL-4438) | MABL-4438 | ELISA, FACS, Functional assay, in vivo binding | G1, Lambda |
| Anti-TIGIT/WUCAM/VSTM3 mAbs [Belrestotug Biosimilar] (MABL-4439) | MABL-4439 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-SARS-CoV-2 Spike RBD mAbs [Beludavimab Biosimilar] (MABL-4440) | MABL-4440 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-FGFR2/CD332 mAbs [Bemarituzumab Biosimilar] (MABL-4441) | MABL-4441 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-IL7R/CD127 mAbs [Bempikibart Biosimilar] (MABL-4442) | MABL-4442 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
联系我们
Copyright © 2012-2029 西安迈博睿（Mabioway）生物科技有限公司 版权所有
地址：陕西省西安市浐灞生态区广运潭大道南段4555号长安大学科技园4号楼A单元2层
电话：15339069646 邮箱：info@mabioway.cn